Table 1.
Characteristics of participants
| With | Without | ||
|---|---|---|---|
| Total | cerebrovascular disease | cerebrovascular disease | |
| (n = 88) | (n = 28) | (n = 60) | |
| Age, years | 57 ± 14 | 66 ± 10 | 54 ± 14 ** |
| Male, n (%) | 56 (63.64%) | 20 (71.43%) | 36 (60%) |
| Diabetes history, n (%) | 34 (38.64%) | 16 (57.14%) | 18 (30%) |
| Hypertension, n (%) | 72 (81.82%) | 24 (85.71%) | 48 (80%) |
| Tobacco smoking, n (%) | 12 (13.64%) | 4 (14.29%) | 8 (13.33%) |
| HD vintage (months) | 34.55 ± 18.57 | 40.86 ± 17.09 | 31.60 ± 18.63 |
| Klotho (pg/ml) | 119.10 ± 47.29 | 91.65 ± 28.19 | 131.90 ± 49.09** |
| Hb (g/L) | 99.94 ± 15.34 | 100.93 ± 13.12 | 99.48 ± 16.36 |
| Ca (mmol/L) | 2.19 ± 0.25 | 2.20 ± 0.23 | 2.18 ± 0.26 |
| P (mmol/L) | 1.90 ± 0.52 | 1.84 ± 0.56 | 1.93 ± 0.50 |
| PTH (pg/ml)a | 460.23 (185.75–538) | 343.32 (185.75–478.5) | 514.78 (176.50–727.75)* |
| SF (ng/ml) a | 410.59 (112–528) | 349.64 (84.5–404.25) | 439.51 (121–582) |
| Serum iron (umol/L) a | 10.99 (8.06–13.30) | 10.92 (8.24–12.58) | 11.02 (7.71–13.52) |
| TIBC (umol/L) | 47.10 ± 9.16 | 46.95 ± 9.65 | 47.18 ± 9.00 |
| Tch (mmol/L) | 3.90 ± 0.99 | 4.05 ± 1.30 | 3.83 ± 0.79 |
| TG (mmol/L) a | 1.51 (0.90–1.80) | 1.74 (1.02–1.74) | 1.41 (0.85–1.82) |
| LDL-C (mmol/L) | 2.20 ± 0.71 | 2.32 ± 0.91 | 2.14 ± 0.59 |
| HDL-C (mmol/L) | 0.96 ± 0.30 | 0.91 ± 0.20 | 0.98 ± 0.34 |
| ALB (g/L) | 40.06 ± 3.56 | 39.14 ± 3.13 | 40.44 ± 3.69 |
Hb hemoglobin, Ca calcium, P phosphate, PTH parathyroid hormone, SF serum ferritin, TIBC Total iron binding capacity, Tch total cholesterol, TG triglycerides, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, ALB albumin
aMedian (25th–75th percentile). *p < 0.05; **p < 0.01